N/A
Completed N=30
LifeFlow Fluid Study- Non- Critical Pediatric Patients Having a Trans Abdominal Ultrasound
Dehydration in Children · Dehydration
Source: ClinicalTrials.gov NCT03712189 ↗
Enrolled (actual)
30
Serious AEs
0.0%
Results posted
Feb 2021
Primary outcomePrimary: Duration- Ultrasound Ordered to Completed — 154.4; 114.8 minutes
Summary
This is an unblinded, randomized control study examining two fluid delivery modalities for non-critical female patients with a planned transabdominal pelvic ultrasound requiring intravenous fluid boluses.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Duration- Ultrasound Ordered to Completed |
154.4; 114.8 | — |
| SECONDARY Total IV Fluid (mL) |
1612.9; 1482.7 | — |
| SECONDARY Duration- Full Bladder |
61.9; 26.9 | — |
Eligibility Criteria
Inclusion Criteria
- Female patients older than 1 month and less than 18 years
- Patients require IV crystalloid bolus fluids before a pelvic ultrasound
Exclusion Criteria
- Known cardiac insufficiency or significant cardiac surgery
- Hepatic insufficiency
- Renal insufficiency
- Any known fluid overload states (ascites, pulmonary edema)
- On any diuretic or antihypertensive therapy
- Known pregnancy
Data sourced from ClinicalTrials.gov (NCT03712189). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.